fbpx
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

Please note, we need you to ….
  • Read the important documents for this study
  • If you are interested, look at the dates that this study is being run (cohort visit planners) and  reply to our email (don’t re-register online) to let us know which cohort(s) you are available for
  • We will ring you to check your suitability and provide further information about the study
  • We will make you a screening appointment at NZCR Auckland. You will need to attend at the scheduled time if you wish to take part in the study

Study Information

New Zealand Clinical Research is trialling an experimental medication that is being developed for the treatment of autoimmune disorders, where the body’s immune system attacks itself, driven by autoantibodies.

Antibodies are proteins that recognise foreign substances in the body, so that the immune system can fight them off. However, in autoimmune disorders, these antibodies, called ‘autoantibodies’ begin to attack the immune system causing autoimmunity. These autoantibodies attack healthy cells in the body and can lead to organ damage.

The experimental medication is designed to lower the levels of these autoantibodies to prevent them from attacking the immune system, in the hopes of providing a potential treatment for autoimmune disorders.

 It is an experimental drug because it has not been approved by MedSafe or other drug regulatory authorities.

Study Candidates

  • Healthy males and females (post menopausal or surgically sterile)
    • Aged 18 – 55 years
    • BMI 18 – 35 kg/m2
    • Smokers allowed
    • Not currently taking any medications

 

What is Involved?

Study Visits: 15 night stay

Outpatient visits: 4 visits

Reimbursement: $9,000 (less tax)

Important Documents

Important documents to download and read

Pre-screening Form

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

Have you had any covid symptoms in the last two weeks or been in isolation?
Have you previously participated in a study with NZCR or any other organisation? Give details or leave blank if no
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you using 2 forms of contraception?
Have you donated blood or plasma in the last few months?
Do you have any history of tuberculosis, or previous exposure to tuberculosis, or have visited: Africa, Russia, Eastern Europe, Asia, Latin America, and the Caribbean (TB endemic regions) in the last 8 weeks?
Any history or current autoimmune disorders? Are you being treated with any immunosuppressive medication? - For e.g., psoriasis, rheumatoid arthritis, Crohn’s disease, or ulcerative colitis etc.
Do you have any history of medical conditions relating to:
If unsure please note down what vaccines you have had in the last month and when.
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 14 days?
Are you available to stay for the 15 nights inpatient stays here at NZCR?(Required)
Participants are not allowed to leave the premises during the inpatient stay.
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. Flexibility for other groups increases your chances of getting into the study.
Screening conditions(Required)
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a night reserve. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
This field is for validation purposes and should be left unchanged.